Indonesia stocks plunge after MSCI says market could be cut from indices
Original Report
Warning from global index provider fuels concerns about investability in south-east Asia’s biggest economy
Glass House Analysis
International economic policy has concrete impacts far beyond diplomatic circles. Tariffs show up in the price of goods at stores, supply chain disruptions affect whether products are on shelves, and trade tensions can mean job losses in export-dependent industries. The globalized economy means that decisions made abroad can affect workers and consumers domestically.
Energy prices affect virtually every aspect of daily life—from commuting costs to heating bills to the price of groceries (which must be transported). For working families, energy represents one of the most volatile and impactful line items in their budgets. Energy policy decisions ripple through the economy, affecting everything from manufacturing competitiveness to household financial stress.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
Tesla reveals next-generation Roadster after almost a decade of delays
Elon Musk first debuted the Roadster refresh concept in 2017 but Tesla has since missed every targeted delivery date.
Indonesia Stocks Sink as MSCI Weighs Index Removal
Indonesian stocks tumbled after MSCI Inc. said the country no longer merits emerging-market status, risking an ejection from its global indexes and triggering fears of foreign capital flight....
China’s National Team Signals Return With Heavy ETF Inflows
China’s state-backed funds appear to be stepping back into the stock market, a sign that Beijing is seeking to put a floor under falling shares.
City Therapeutics Raises $200 Million in Upsized US IPO
City Therapeutics Inc., an early-stage developer of RNAi-based drugs, raised $200 million in a US initial public offering priced at the mid-point of its marketed range.